<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
FILED PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934 AND RULE 13A-17
OR 15D-17 THEREUNDER
GULF SOUTH MEDICAL SUPPLY, INC.
(Exact name of issuer as specified in charter)
426 CHRISTINE DRIVE, RIDGELAND, MISSISSIPPI 39157
(Address of principal executive offices)
Issuer's telephone number, including area code: (601) 856-5900
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of five percent or more in the
number of shares outstanding:
1. Title of security: Common Stock, $.01 Par Value
2. Number of shares outstanding before the change: 14,040,847
3. Number of shares outstanding after the change: 16,264,123
4. Effective date of change: June 12, 1996
5. Method of change: Specify method (such as merger, acquisition, exchange,
distribution, stock split, reverse split, acquisition of stock for
treasury, etc.) Public offering
Give brief description of transaction: In connection with a public offering of
3,000,000 shares of Common Stock by the issuer and certain selling
stockholders, the issuer issued 2,223,276 shares of Common Stock.
II. CHANGE IN NAME OF ISSUER
1. Name prior to change: N/A
2. Name after change: N/A
3. Effective date of charter amendment changing name: N/A
4. Date of shareholder approval of change, if required: N/A
<TABLE>
<S> <C>
June 18, 1996 /s/ Stanton Keith Pritchard, Vice President Corporate Development
- ------------------ -----------------------------------------------------------------
Date (Officer's signature and title)
</TABLE>
